Lv4
440 积分 2024-06-05 加入
Ruxolitinib combined with etanercept induce a rapid response to corticosteroid‐refractory severe acute graft vs host disease after allogeneic stem cell transplantation: Results of a multi‐center prospective study
1个月前
已完结
Real-world experience with ruxolitinib therapy for steroid-refractory acute graft versus host disease
1个月前
已完结
Ruxolitinib versus basiliximab for steroid-refractory acute graft-versus-host disease: a retrospective study
1个月前
已完结
Basiliximab for steroid‐refractory acute graft‐versus‐host disease: A real‐world analysis
1个月前
已完结
Ruxolitinib combined with etanercept induce a rapid response to corticosteroid‐refractory severe acute graft vs host disease after allogeneic stem cell transplantation: Results of a multi‐center prospective study
1个月前
已完结
Ruxolitinib Plus Basiliximab Therapy for Steroid-Refractory Acute Graft-Versus-Host Disease in Unrelated Cord Blood Transplantation: A Large-Scale Study
1个月前
已完结
Ruxolitinib versus basiliximab for steroid-refractory acute graft-versus-host disease: a retrospective study
1个月前
已完结
The role of ruxolitinib in the management of acute GVHD
1个月前
已完结
Approved and emerging therapies for glucocorticoid-refractory chronic graft-versus-host disease
1个月前
已完结
T Cell Subsets in Graft Versus Host Disease and Graft Versus Tumor
1个月前
已完结
Efficient CRISPR/Cas9 Gene Editing in Uncultured Naive Mouse T Cells for In Vivo Studies
皖公网安备34019202002308
